WillItSurvive
Medical technology and health companies · United States

Align Technology

aligntech.com ↗

Makes Invisalign clear aligners and iTero scanners used by orthodontists worldwide.

Defensible for now
Assessed 22 July 2026 · Evidence as of 22 July 2026
Real protection, with named pressure against it.
On the recordSince 22 July 2026 · Checkable from July 29, 2026 · Every call on the record Checkpoint: Align Q2 2026 earnings call, watch ASP and shipment growth vs. market
The call

Align still leads clear aligners by a wide margin, but cheaper rivals and an EU probe into its scanner tie-in are testing how long that lead holds.

Align Technology sells Invisalign, the invisible braces that straighten teeth, along with iTero scanners that dentists use to take 3D images and place orders. The company owns about 70% of the clear-aligner market worldwide because it has scanned 22.8 million patients since 1997, holds regulatory approvals most competitors lack, and embeds its scanners in tens of thousands of dental offices, making it easy for dentists to order Invisalign. However, growth has nearly stopped (less than 1% last year), rivals like Angel Aligner and Spark are growing much faster with cheaper products now that Align's old patents expired, and the European Union is investigating whether Align illegally ties its scanners to its braces to lock out competitors. The key question is whether the company can hold prices and market share when cheaper alternatives exist or whether regulators force it to let dentists use iTero scanners to order from other companies.

Why
01
AI pressure: Shanghai Smartee and other AI-assisted aligner design platforms. AI treatment-planning tools let low-cost rivals design aligners fast without Align's scanner network. Could AI do the core job? Unlikely.
02
Bigger players: Straumann ClearCorrect and Envista Spark. Both post double-digit growth while Align's shipments grow near flat, chipping at its 68.8% share. Could a giant copy it? No, they are blocked.
03
What protects it. 125,000+ iTero scanners tied into 300,000 doctor workflows, backed by 22.8 million patient scans.
What would change this call
Align's Q2 2026 earnings (July 29, 2026) show ASP or shipment growth trailing overall market growth. Would confirm low-cost rivals like Angel Aligner are eroding pricing power and share.
EU antitrust ruling forces open the iTero scanner to Invisalign ordering link. Would weaken the workflow lock-in that keeps doctors funneling orders to Align.
Straumann or Envista report clear-aligner unit growth sustained above 10% in upcoming quarterly results. Would show named rivals converting Align's expired patents into durable share gains.
Key numbers
  • 68.8% global clear-aligner share (2025)
  • FY2025 revenue growth only 0.9% (2025)
  • Q1 2026 ASP $1,250, up 1% YoY (2026-Q1)
Named risks
  • EU antitrust probe could force scanner-aligner interoperability, weakening core lock-in. Severity: high
  • Patent expirations since 2017 letting low-cost generic aligner entrants erode pricing. Severity: medium
  • Headcount decline for four straight years despite revenue growth, signaling internal strain. Severity: medium
  • Resin, freight cost inflation and geopolitical exposure flagged for 2026 margins. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Angel Alignergaining onFast-growing Chinese rival enabled by expired patents, cited as double-digit growth threat in 2025 reports
Straumann ClearCorrectgaining onPosted double-digit growth in ClearCorrect/digital solutions in 2024
Envista SparkcontestingDescribed as the #2 player by sales in clear aligners as of June 28, 2026
Shanghai Smarteegaining onVendor-claimed seconds-level AI-assisted plan edits, noted in 2025 competitive profile
SmileDirectClublosing toWound down entirely in December 2023 after Align won $43.4M arbitration award in 2021
Questions people ask
Is Align Technology profitable in 2026?
Yes. Align reported Q1 2026 revenue of $1.04 billion, up 6.2% YoY, with adjusted EPS of $2.58, beating consensus by about 14%, according to a July 14, 2026 earnings summary.
What is Align Technology's market share in clear aligners?
Align held an estimated 68.8% of the global clear-aligner market in 2025, per an industry market report published June 30, 2026, making it the dominant player ahead of rivals like Angel Aligner and Envista Spark.
Is Align Technology facing antitrust trouble?
Yes. The European Commission opened a formal antitrust investigation on June 30, 2026 into whether Align illegally tied iTero scanners to Invisalign orders in the EEA, its first formal medical-device antitrust probe.
Who are Align Technology's biggest competitors?
Key rivals include Straumann's ClearCorrect (double-digit growth in 2024), Envista's Spark (called #2 by sales as of June 2026), China's fast-growing Angel Aligner, Dentsply Sirona's Byte, and Shanghai Smartee.
Is Align Technology laying off employees?
Headcount has fallen for four straight years, from a 2022 peak of 23,165 to 20,290 at end-2025, a 3.13% drop, even as the company plans a new Hyderabad, India factory opening in 2027.
Could AI replace Align Technology's business?
Unlikely soon. Align's core is regulated physical manufacturing plus a proprietary dataset of 22.8 million patient scans and 125,000+ iTero scanners; AI tools like X-ray Insights (March 2025) augment rather than replace this workflow.
Timeline
  • 2026-07-01Kevin Conroy becomes Align Chairman, succeeding retiring C. Raymond Larkin Jr.
  • 2026-06-30European Commission opens formal antitrust probe into iTero-Invisalign tying practice.
  • 2026-05-01Align previews new Invisalign features including 3D-printed attachments at AAO 2026.
  • 2026-04-29Align authorizes $200 million stock buyback.
  • 2025-12-08Invisalign mandibular advancement system launch expands to Thailand and Asia.
  • 2025-03-11Align X-ray Insights AI diagnostic software launches in EU and UK.
  • 2023-12Rival SmileDirectClub winds down operations entirely.
  • 2022-09-28Align launches next-gen Invisalign Virtual Care AI remote monitoring.
  • 2022Align headcount peaks at 23,165 employees.
Revision history
22 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
AbridgeSeegeneOlympus Corporation
More in Medical technology and health companies →
Sources